drugset / Trial / NCT00368641
Heart Failure and Peritoneal Ultrafiltration
Phase 2
Terminated
12 enrolled
Vantive Health LLC
Baxter Healthcare Corporation (Former Sponsor) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of the study is to determine if the addition of peritoneal ultrafiltration to standard therapy in treatment-resistant severe heart failure patients will improve fluid balance and functional capacity such that they will spend less time in the hospital and have an improved ambulatory quality of life in comparison to patients who remain on standard therapy alone.
Timeline
- Start
- 2006-08
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Icodextrin | Other / unclassified | — | — |